Efficacy and safety of targeting VEGFR drugs in treatment for advanced or metastatic gastric cancer: a systemic review and meta-analysis

The value of targeting VEGFR (vascular endothelial growth factor receptor) drugs has demonstrated encouraging anti-cancer activity in advanced solid tumors within current clinical trials. This study aimed to serve as the first systemic review to assess their safety and efficacy according to biochemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Duanrui, Ma, Xiaoli, Xiao, Dongjie, Jia, Yanfei, Wang, Yunshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814287/
https://www.ncbi.nlm.nih.gov/pubmed/29487720
http://dx.doi.org/10.18632/oncotarget.23429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814287/
https://www.ncbi.nlm.nih.gov/pubmed/29487720
http://dx.doi.org/10.18632/oncotarget.23429

Ejemplares similares